Related Experiment Video
Updated: Jun 12, 2026

Proximity Ligand Assay to Localize Proteins in DNA Damage Sites
Published on: August 2, 2024
p73 participates in male germ cells apoptosis induced by etoposide
Verónica A Codelia1, Matías Cisterna, Alejandra R Alvarez
1Departamento de Ciencias Fisiológicas, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Alameda 340, Santiago, Chile.
Abstract:
Etoposide is a commonly used drug in testicular cancer chemotherapy. However, the molecular pathways that activate germ cell apoptosis in response to etoposide are poorly understood. The aim of this study was to evaluate the participation of p73, a member of the p53 family, in apoptosis induced by etoposide in male germ cells. First, we used GC2-spc cells-a male germ cell model-to evaluate apoptotic signaling after treatment of etoposide. We found an important increase in p73 protein levels, along with the c-Abl kinase, its physiological activator, in response to etoposide. This increase was accompanied by a decrease in cell viability and activation of caspase-3. Pifithrin (PFT) treatment prevented p73 increase and apoptosis induced by etoposide. Also, the in vitro knockdown of p73 or p53 by shRNA, significantly prevented the decrease in cell viability after etoposide treatment. In an in vivo model-21-day-old rat testes-we observed an up-regulation of the protein levels of p73 and phosphorylated p73-at c-Abl site Tyr99-in response to the etoposide injection. STI571 (a pharmacological inhibitor of c-Abl) or PFT co-injection prevented etoposide-induced up-regulation of phospho-p73 and pro-apoptotic TAp73 isoform levels. Moreover, caspases-3, -8, -9 activation and germ cell death induced by etoposide were significantly decreased by these drugs. These results support the notion that the c-Abl/p73 pathway is activated in germ cells after etoposide treatment, triggering apoptosis, possibly assisting p53.
Insights
The c-Abl/p73 pathway activates germ cell apoptosis following etoposide treatment in testicular cancer. Inhibiting this pathway reduces cell death, suggesting a new therapeutic target.
Area of Science:
- Molecular Biology
- Cell Death Research
- Cancer Therapeutics
Background:
- Etoposide is a key chemotherapy for testicular cancer, but its mechanism of germ cell apoptosis induction is unclear.
- Understanding these pathways is crucial for improving treatment efficacy and minimizing side effects.
Purpose of the Study:
- To investigate the role of p73, a p53 family member, in etoposide-induced apoptosis in male germ cells.
- To elucidate the involvement of the c-Abl kinase in this process.
Main Methods:
- Utilized GC2-spc cells (male germ cell model) and in vivo rat testes models.
- Assessed protein levels (p73, c-Abl, phospho-p73), cell viability, and caspase activation.
- Employed etoposide treatment, Pifithrin (PFT), STI571 (c-Abl inhibitor), and shRNA knockdown (p73/p53).
Main Results:
- Etoposide increased p73 and c-Abl levels, decreased cell viability, and activated caspase-3 in GC2-spc cells.
- PFT and p73/p53 knockdown inhibited etoposide-induced apoptosis.
- In vivo, etoposide upregulated p73 and phospho-p73; co-administration of STI571 or PFT reduced apoptosis and caspase activation.
Conclusions:
- The c-Abl/p73 pathway is activated by etoposide in male germ cells, leading to apoptosis.
- This pathway may act in concert with p53, offering potential therapeutic targets for testicular cancer treatment.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy

